Company intelligence / Profile preview

Beyond Type 1

San Mateo, California, United States

Ownership: Private
Employees: ~28
Development stage: Other

Overview

Beyond Type 1 is a nonprofit diabetes organization focused on education, advocacy, community support, and access/affordability initiatives rather than on developing therapeutic products or conducting its own clinical trials.[2][5]

Therapeutic areas: Endocrinology
Industry: Non-Academic Healthcare

Partnerships

Dexcom (through National Glucose Awareness Week partnership via Beyond Type 2)[1]Multiple diabetes technology and pharma partners in programs like GetInsulin.org and broader diabetes access/education initiatives (not always listed by name on the main site)[2][5]

Beyond the preview

Go deeper on Beyond Type 1.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Beyond Type 1.

Explore the full profile